[go: up one dir, main page]

ZA977216B - Immortalized cell lines for virus growth. - Google Patents

Immortalized cell lines for virus growth.

Info

Publication number
ZA977216B
ZA977216B ZA9707216A ZA977216A ZA977216B ZA 977216 B ZA977216 B ZA 977216B ZA 9707216 A ZA9707216 A ZA 9707216A ZA 977216 A ZA977216 A ZA 977216A ZA 977216 B ZA977216 B ZA 977216B
Authority
ZA
South Africa
Prior art keywords
cell lines
immortalized cell
virus growth
virus
growth
Prior art date
Application number
ZA9707216A
Other languages
English (en)
Inventor
Douglas N Foster
Linda K Foster
Original Assignee
Univ Minnesota
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Minnesota filed Critical Univ Minnesota
Publication of ZA977216B publication Critical patent/ZA977216B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10Cells modified by introduction of foreign genetic material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0652Cells of skeletal and connective tissues; Mesenchyme
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86Viral vectors
    • C12N15/867Retroviral vectors
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00Genetically modified cells
    • C12N2510/02Cells for production
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00Genetically modified cells
    • C12N2510/04Immortalised cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/16011Herpesviridae
    • C12N2710/16611Simplexvirus, e.g. human herpesvirus 1, 2
    • C12N2710/16651Methods of production or purification of viral material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011Details
    • C12N2720/12011Reoviridae
    • C12N2720/12051Methods of production or purification of viral material

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Rheumatology (AREA)
  • Plant Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
ZA9707216A 1996-08-13 1997-08-12 Immortalized cell lines for virus growth. ZA977216B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/696,200 US5672485A (en) 1996-08-13 1996-08-13 Immortalized cell lines for virus growth

Publications (1)

Publication Number Publication Date
ZA977216B true ZA977216B (en) 1998-02-19

Family

ID=24796108

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9707216A ZA977216B (en) 1996-08-13 1997-08-12 Immortalized cell lines for virus growth.

Country Status (28)

Country Link
US (4) US5672485A (de)
EP (1) EP0920491B1 (de)
JP (3) JP3754088B2 (de)
KR (1) KR100375871B1 (de)
CN (1) CN1228119B (de)
AR (1) AR008294A1 (de)
AT (1) ATE362524T1 (de)
AU (1) AU726820B2 (de)
BR (1) BR9711067A (de)
CA (1) CA2263725C (de)
CO (1) CO4700552A1 (de)
DE (1) DE69737735T2 (de)
DK (1) DK0920491T3 (de)
DZ (1) DZ2291A1 (de)
ES (1) ES2285738T3 (de)
GT (1) GT199700091A (de)
HN (1) HN1997000124A (de)
HU (1) HU226658B1 (de)
IL (4) IL158301A0 (de)
MA (1) MA24303A1 (de)
MY (1) MY125594A (de)
NZ (1) NZ334147A (de)
PE (1) PE108198A1 (de)
PT (1) PT920491E (de)
SV (1) SV1997000071A (de)
UY (1) UY24668A1 (de)
WO (1) WO1998006824A1 (de)
ZA (1) ZA977216B (de)

Families Citing this family (62)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5672485A (en) * 1996-08-13 1997-09-30 Regents Of The University Of Minnesota Immortalized cell lines for virus growth
US6150505A (en) * 1997-09-19 2000-11-21 Hadasit Medical Research Services & Development Ltd. Fibrin microbeads prepared from fibrinogen, thrombin and factor XIII
US6821741B1 (en) 2001-04-27 2004-11-23 University Hospitals Of Cleveland Cells for detection of enteroviruses
US6552172B2 (en) * 2001-08-30 2003-04-22 Habto Biotech, Inc. Fibrin nanoparticles and uses thereof
US20040023358A1 (en) * 2001-12-21 2004-02-05 Wyeth Avian embryo particulate biomass for the production of virus antigens
FR2836924B1 (fr) 2002-03-08 2005-01-14 Vivalis Lignees de cellules aviaires utiles pour la production de substances d'interet
US20090217404A1 (en) * 2002-09-27 2009-08-27 Lowe Scott W Cell-based RNA interference and related methods and compositions
US7410557B2 (en) * 2002-09-30 2008-08-12 Honda Motor Co., Ltd. Hydrogen activating apparatus
CA2510229A1 (en) * 2002-12-13 2004-07-08 Aventis Pasteur, Inc. Production of alvac on avian embryonic stem cells
DK1599573T3 (da) * 2003-02-17 2013-07-08 Cold Spring Harbor Lab Model til at studere genernes rolle i tumorresistens over for kemoterapi
US20090186839A1 (en) * 2003-02-17 2009-07-23 Cold Spring Harbor Laboratory Model for studying the role of genes in chemoresistance
US20040255345A1 (en) * 2003-03-07 2004-12-16 Rapp Jeffrey C. Production of transgenic avians
EP1608219A4 (de) * 2003-03-07 2007-03-14 Avigenics Inc Integrase-vermittelte vogeltransgenese
US20050198700A1 (en) * 2003-03-07 2005-09-08 Avigenics, Inc. Genomic modification
US20050273873A1 (en) * 2003-03-07 2005-12-08 Avigenics, Inc. Genomic modification
US20050034186A1 (en) * 2003-03-07 2005-02-10 Harvey Alex J. Site specific nucleic acid integration
EP2143788A1 (de) 2003-07-22 2010-01-13 Vivalis Produktion von Pockenviren mit Entenzelllinien
WO2005028634A2 (en) * 2003-09-18 2005-03-31 Emory University Improved mva vaccines
EP1528101A1 (de) 2003-11-03 2005-05-04 ProBioGen AG Immortalisierte Vogel-Zelllinien für die Produktion von Viren
US20060123504A1 (en) * 2004-12-07 2006-06-08 Avigenics, Inc. Methods of producing polyclonal antibodies
US20060174364A1 (en) * 2004-03-01 2006-08-03 Avigenics, Inc. Artificial chromosomes and transchromosomic avians
WO2006042214A1 (en) * 2004-10-08 2006-04-20 Avigenics, Inc. Modified integrase and methods of use
US8137907B2 (en) * 2005-01-03 2012-03-20 Cold Spring Harbor Laboratory Orthotopic and genetically tractable non-human animal model for liver cancer and the uses thereof
FR2884255B1 (fr) 2005-04-11 2010-11-05 Vivalis Utilisation de lignees de cellules souches aviaires ebx pour la production de vaccin contre la grippe
US20070044164A1 (en) * 2005-05-31 2007-02-22 Cold Spring Harbor Laboratory Methods for producing microRNAs
US7524626B2 (en) * 2005-10-05 2009-04-28 Synageva Biopharma Corp. Rapid production of high titer virus
HUE030533T2 (hu) 2006-06-20 2017-05-29 Transgene Sa Eljárás poxvírusok és poxvírus-készítmények elõállítására
CN100443588C (zh) * 2006-12-11 2008-12-17 中国农业科学院北京畜牧兽医研究所 静宁鸡胚成纤维细胞系及其培养方法
US8213704B2 (en) * 2007-05-09 2012-07-03 Kla-Tencor Corp. Methods and systems for detecting defects in a reticle design pattern
EP2014279A1 (de) * 2007-06-22 2009-01-14 Pevion Biotech AG Virosomen enthaltend Haemagglutinin, das von über Zelllinien hergestellten Influenza-Viren stammt, Zusammensetzungen, Herstellungsverfahren, Verwendung davon
US8357531B2 (en) * 2007-07-03 2013-01-22 Transgene S.A. Immortalized avian cell lines
WO2009004016A1 (en) * 2007-07-03 2009-01-08 Transgene S.A. Immortalized avian cell lines
US8901288B2 (en) * 2007-10-26 2014-12-02 Cold Spring Harbor Laboratory High throughput methods for functionally determining RNA interference efficiency
RU2509803C2 (ru) 2008-02-25 2014-03-20 Бакстер Интернэшнл Инк. Способ получения непрерывных клеточных линий и их применение
EP2429579A1 (de) 2009-05-12 2012-03-21 Transgene SA Immortalisierte vogel-zelllinien und ihre verwendung
WO2010144797A2 (en) 2009-06-12 2010-12-16 Vaccine Technologies, Incorporated Influenza vaccines with enhanced immunogenicity and uses thereof
AU2011281982B2 (en) 2010-07-20 2015-12-17 Bavarian Nordic A/S Method for harvesting expression products
FR3008992A1 (fr) 2013-07-25 2015-01-30 Agronomique Inst Nat Rech Procede de selection d'une lignee cellulaire permissive pour la replication de virus aviaires
RU2704485C2 (ru) 2014-12-01 2019-10-29 Трансген Са Стабильные жидкие препараты вируса осповакцины
PL3227433T3 (pl) * 2014-12-04 2019-01-31 Intervet International B.V. Unieśmiertelnione fibroblasty zarodków kurzych
ES3011733T3 (en) 2015-02-13 2025-04-08 Transgene Immunotherapeutic vaccine and antibody combination therapy
KR101768581B1 (ko) * 2015-08-13 2017-08-17 전북대학교 산학협력단 자발적 불멸화된 체세포의 단일 세포로부터 리프로그래밍 세포주의 제조방법
US20190144831A1 (en) * 2015-12-11 2019-05-16 Intervet Inc. Immortalised chicken embryonic epithelial kidney cells
US20190134190A1 (en) 2016-05-04 2019-05-09 Transgene Sa Combination therapy with cpg tlr9 ligand
IL291373B2 (en) * 2016-07-11 2023-10-01 Yissum Res Dev Co Of Hebrew Univ Jerusalem Ltd Methods and systems for growing cells in culture
WO2018069316A2 (en) 2016-10-10 2018-04-19 Transgene Sa Immunotherapeutic product and mdsc modulator combination therapy
WO2018093903A1 (en) 2016-11-17 2018-05-24 Regents Of The University Of Minnesota Immortalized cell lines and methods of use
WO2018210804A1 (en) 2017-05-15 2018-11-22 Janssen Vaccines & Prevention B.V. Stable virus-containing composition
AU2018270375B2 (en) 2017-05-15 2025-04-17 Bavarian Nordic A/S Stable virus-containing composition
AU2018287159B2 (en) 2017-06-21 2025-01-16 Transgene Personalized vaccine
CN107858323B (zh) * 2017-11-08 2020-10-09 广东省生物资源应用研究所 一种红耳龟胚胎成纤维细胞系及其构建方法
CN109234239B (zh) * 2018-07-13 2021-09-14 广东永顺生物制药股份有限公司 一种鸭瘟病毒的培养方法
EP3847246A1 (de) 2018-09-06 2021-07-14 Bavarian Nordic A/S Pockenviruszusammensetzungen mit verbesserter lagerung
US20230031097A1 (en) 2019-12-20 2023-02-02 Intervet Inc. Multivalent hvt vector vaccine
IL296250A (en) 2020-03-12 2022-11-01 Bavarian Nordic As The compounds that improve the stability of the smallpox virus
CN116322740A (zh) 2020-07-13 2023-06-23 特兰斯吉恩股份有限公司 免疫抑制的治疗
JP2023539771A (ja) 2020-09-07 2023-09-19 インターベット インターナショナル ベー. フェー. Ha抗体陽性ターゲットのためのhaステムワクチン
US20240058436A1 (en) 2020-12-24 2024-02-22 Intervet Inc. Multivalent hvt vector vaccine
EP4370150A1 (de) 2021-07-13 2024-05-22 Intervet International B.V. Überwindung von antikörperinterferenz bei vögeln
WO2023213764A1 (en) 2022-05-02 2023-11-09 Transgene Fusion polypeptide comprising an anti-pd-l1 sdab and a member of the tnfsf
WO2023213763A1 (en) 2022-05-02 2023-11-09 Transgene Poxvirus encoding a binding agent comprising an anti- pd-l1 sdab
JP2025515050A (ja) 2022-05-05 2025-05-13 インターベット インターナショナル ベー. フェー. 新規多価hvtベクターワクチン

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3058438B2 (ja) * 1990-10-19 2000-07-04 財団法人化学及血清療法研究所 ヒト肝臓組織特異的ウイルスの感染可能な霊長類の不死化肝細胞およびその調製方法
US5672485A (en) * 1996-08-13 1997-09-30 Regents Of The University Of Minnesota Immortalized cell lines for virus growth

Also Published As

Publication number Publication date
EP0920491B1 (de) 2007-05-16
WO1998006824A1 (en) 1998-02-19
US5879924A (en) 1999-03-09
JP2005118053A (ja) 2005-05-12
JP3754088B2 (ja) 2006-03-08
MY125594A (en) 2006-08-30
JP2006320328A (ja) 2006-11-30
KR100375871B1 (ko) 2003-03-10
ATE362524T1 (de) 2007-06-15
EP0920491A1 (de) 1999-06-09
DE69737735D1 (de) 2007-06-28
HUP0000188A3 (en) 2005-11-28
CA2263725C (en) 2002-10-15
SV1997000071A (es) 2000-07-06
DK0920491T3 (da) 2007-09-17
CA2263725A1 (en) 1998-02-19
CN1228119A (zh) 1999-09-08
CN1228119B (zh) 2012-04-04
MA24303A1 (fr) 1998-04-01
HUP0000188A2 (hu) 2000-06-28
UY24668A1 (es) 1998-02-02
US5985642A (en) 1999-11-16
HN1997000124A (es) 1999-03-19
IL158302A0 (en) 2004-05-12
IL158303A0 (en) 2004-05-12
PT920491E (pt) 2007-07-27
DZ2291A1 (fr) 2002-12-25
BR9711067A (pt) 1999-08-17
AU726820B2 (en) 2000-11-23
GT199700091A (es) 1997-08-12
NZ334147A (en) 2000-08-25
AU4069197A (en) 1998-03-06
US5672485A (en) 1997-09-30
PE108198A1 (es) 1999-01-21
AR008294A1 (es) 1999-12-29
KR20000029968A (ko) 2000-05-25
ES2285738T3 (es) 2007-11-16
IL128511A (en) 2004-06-01
HK1022496A1 (en) 2000-08-11
JP2000516095A (ja) 2000-12-05
HU226658B1 (en) 2009-06-29
IL158301A0 (en) 2004-05-12
CO4700552A1 (es) 1998-12-29
DE69737735T2 (de) 2008-01-31
IL128511A0 (en) 2000-01-31
US6207415B1 (en) 2001-03-27

Similar Documents

Publication Publication Date Title
ZA977216B (en) Immortalized cell lines for virus growth.
AU4322797A (en) Protruding case for mail
ZA9610870B (en) Electroconversion cell.
AU3414199A (en) Scanner system
ZA978256B (en) Electrolyte.
EP0892850A4 (de) Immortalisierte hepatozyten
AU5569499A (en) Livestock sorting system
ZA9710861B (en) Cell-culture system.
IL130264A0 (en) Adaptive predistortion system
AU2644199A (en) Transport system
ZA977215B (en) Method for immortalizing cells.
ZA9711103B (en) Plant support.
ZA985135B (en) Plant grab proteins.
ZA978494B (en) Method for inhibiting the growth of mammalian cells.
GB9605453D0 (en) Cultured cells
AU3228197A (en) Cell growth regulatory genes
AU4225797A (en) Methods for culturing cells
AU3711097A (en) Electrochemical plant
HUP9903778A3 (en) Bioreactor
AU5385499A (en) Conveyor system
GB9619597D0 (en) Culture system
GB9618249D0 (en) Cell culture
GB2384386B (en) System for providing halftone
GB9808923D0 (en) Culture systems
AUPP525498A0 (en) Hold time system